The research environment at the department of clinical neurophysiology has resulted in the development of groundbreaking methods such as single-fiber electromyography and improved diagnostics for patients with intractable epilepsy.
The current research focus at the department of Clinical Neurophysiology aims at improving diagnostic and monitoring tools in neuromuscular disorders, including biomarkers and neurophysiology, both in-vivo and in-vitro, as well as novel treatment options. Dr Punga holds multiple highly competitive national research grants from the Swedish Research Council and was recently awarded Göran Gustafssons large prize in medicine for the research group´s studies in the neuromuscular disorder myasthenia gravis (MG). Dr Punga´s team has pioneered the field of microRNA biomarker discovery in MG and has several publications on this topic. Further, the team has established an in-vitro multielectrode chip model with recording of 24 600 electrodes for culture of muscle cells and neurons, to simulate healthy and disease states. For more information see:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6190753/pdf/fphys-09-01424.pdf
The members of the central and somatosensory nervous system research group focus mainly on improving the localization of epileptic foci as well as developing novel methods in intraoperative monitoring and during intensive care.